Skip to content

Avenanthramide and Saponin Bioavailability in Oat Bran

Avenanthramide and Saponin Bioavailability in Oat Bran

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04335435
Enrollment
13
Registered
2020-04-06
Start date
2016-01-15
Completion date
2016-01-21
Last updated
2020-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Health, Pharmacokinetics, Polyphenols

Keywords

Avenanthramides, Saponins, bioavailability, polyphenols, oat bran, pharmacokinetics

Brief summary

Avenanthramides and saponins are types of chemical compounds found naturally in oats. Avenanthramides have anti-oxidant properties, anti-atherosclerotic, anti-inflammation, and anti-proliferative effects on cancer cells in vitro. Oat saponins, or avenacosides, have the ability to bind cholesterol, and thus, the ability to lower blood cholesterol. Oat bran is a known source of these dietary compounds. This study aims to determine the bioavailability of these compounds to in the urine of participants after ingesting an oat bran cereal, both before, and after for multiple time points. Analytical chemistry will be used to determine the bioavailability of the oat compounds at each time point. This will help to establish a kinetic curve for the metabolism of these compounds.

Detailed description

Initially, the diet of the participants will be asked to restricted to avoid eating any polyphenols that might interfere with the employed analytical chemistry techniques. This period of diet restriction is the washout period. The list of foods to avoid are: oats, whole grains, fruits, vegetables, herbal supplements, ginger, coffee, tea, and chocolate. After the washout period, a baseline urine and fecal sample will be collected from the participants, then a large portion of oat bran will be provided to the participants for consumption. The approximate portion size will be 100 g by dry weight. The participants will then provide urine samples during the designated time points. The time points for the urine collection are as follows: 1. st sample, \ 30 min to 1 hour prior to oat consumption 2. nd sample: 0-2 hours after oat consumption 3. rd sample: 2-4 hours after oat consumption 4. th sample: 4-6 hours after oat consumption 5. th sample: 6-9 hours after oat consumption 6. th sample: 9-12 hours after oat consumption 7. th sample: 12-24 hours after oat consumption 8. th sample: 24-32 hours after oat consumption 9. th sample: 48 hours after oat consumption These samples will be analyzed in using HPLC and LC/MS.

Interventions

DIETARY_SUPPLEMENTOat Bran Consumption

Oat bran (120 g), single dose.

Sponsors

North Carolina Agriculture & Technical State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18.5-25 * Have blood and urine biochemical markers in normal range * Have no known allergy to oat relate foods * Be not taking antibiotics for six months * Be not currently taking medication * Be nonsmoking * Have no alcoholic intoxication * Have no extensive exposure to industrial waste

Exclusion criteria

* Individuals with gout * Individuals with heart disease * Individuals with peripheral vascular diseases * Individuals with degenerative liver * Cancer patients * Patients with diabetes * Individuals with GI disorders * Individuals with endocrine disorders

Design outcomes

Primary

MeasureTime frameDescription
Bioavailability of Avenanthramides and Saponins in Urine0-2 hours post-doseLiquid chromatography-tandem mass spectrometry will be utilized to assess the bioavailability of avenanthramides and saponins in urine.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026